Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jordan

Showing results (591-600 of 682) with videos related to

Pageof 69
Sort By:
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Leukemia Research|April 23, 2019
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysisBrett Stevens, Amanda Winters, Jonathan A Gutman, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
The Veterinary Record|July 16, 1983
A standard technique for haemagglutination inhibition tests for antibodies to avian infectious bronchitis virusD J Alexander, W H Allan, P M Biggs, et al.
Nature Medicine|December 7, 2016
Erratum: Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infectionJoseph P Zackular, Jessica L Moore, Ashley T Jordan, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and RelapseTzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Neurology|November 4, 2022
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRIK Ina Ly, Vanessa L Merker, Wenli Cai, et al.
Cell Metabolism|January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AMLAng Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Blood|July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progressionTzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
Nature Medicine|November 8, 2016
Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infectionJoseph P Zackular, Jessica L Moore, Ashley T Jordan, et al.
Pageof 69

Showing results (591-600 of 682) with videos related to

Sort By:
Pageof 69
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Leukemia Research|April 23, 2019
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysisBrett Stevens, Amanda Winters, Jonathan A Gutman, et al.
Nature Cancer|April 22, 2021
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsBrett M Stevens, Courtney L Jones, Daniel A Pollyea, et al.
The Veterinary Record|July 16, 1983
A standard technique for haemagglutination inhibition tests for antibodies to avian infectious bronchitis virusD J Alexander, W H Allan, P M Biggs, et al.
Nature Medicine|December 7, 2016
Erratum: Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infectionJoseph P Zackular, Jessica L Moore, Ashley T Jordan, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Targeting IL-1/IRAK1/4 signaling in Acute Myeloid Leukemia Stem Cells Following Treatment and RelapseTzu-Chieh Ho, Mark W LaMere, Hiroki Kawano, et al.
Neurology|November 4, 2022
Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRIK Ina Ly, Vanessa L Merker, Wenli Cai, et al.
Cell Metabolism|January 30, 2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD<sup>+</sup> to eradicate KRAS-driven AMLAng Jia, Xiaowen Zhang, Ji-Hao Zhou, et al.
Blood|July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progressionTzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
Nature Medicine|November 8, 2016
Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infectionJoseph P Zackular, Jessica L Moore, Ashley T Jordan, et al.
Pageof 69